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The epithelium of the cornea is continuously exposed to pathogens, and adhesion to
epithelial cells is regarded as an essential first step in bacterial pathogenesis. In this article,
the involvement of glycosaminoglycans in the adhesion of various pathogenic bacteria
to corneal epithelial cells is analyzed. All microorganisms use glycosaminoglycans
as receptors, but arranged in different patterns depending on the Gram-type of the
bacterium. The heparan sulfate chains of syndecans are the main receptors, though
other molecular species also seem to be involved, particularly in Gram-negative bacteria.
Adherence is inhibited differentially by peptides, including heparin binding sequences,
indicating the participation of various groups of Gram-positive, and -negative adhesins.
The length of the saccharides produces a major effect, and low molecular weight chains
inhibit the binding of Gram-negative microorganisms but increase the adherence of
Gram-positives. Pathogen adhesion appears to occur preferentially through sulfated
domains, and is very dependent on N- and 6-O-sulfation of the glucosamine residue
and, to a lesser extent, 2-O sulfation of uronic acid. These data show the differential
use of corneal receptors, which could facilitate the development of new anti-infective
strategies.
Keywords: glycosaminoglycans, proteoglycans, cornea, bacterial pathogenesis, bacterial keratitis
INTRODUCTION
Corneal infections affect around 500,000 patients globally and can lead to reduced visual acuity,
irreversible scaring, and blindness (Wilhelmus, 2002; Bourcier et al., 2003; Jinno and Park,
2015). The cornea is the major refractive element of the adult eye, and consists of three
layers, including a thick middle layer known as the stroma, separated by basement membranes
García et al. Bacterial Adherence to Corneal Cells
from an external stratified epithelium and an inner layer of
endothelial cells. The corneal epithelium is the interface with the
environment and represents an active barrier against pathogens,
commensal bacteria, toxic stimuli, and allergens (Lambiase et al.,
2011). Due to the constant physical disruption of blinking and
tear flow, in addition to the presence of antibacterial components,
the ocular surface of healthy individuals inherently supports
a small population of bacteria (Graham et al., 2007). The
development of infectious processes in the cornea necessarily
involves the participation of pattern-recognition receptors that
allow the adherence and colonization by pathogens. These
receptors may not only be involved in the anchoring of the
bacteria, but also in other aspects of the infectious process such
as tissue tropism, the triggering of host response, or microbial
invasion (Wilson et al., 2002). Some previous studies have
shown the involvement of glycosaminoglycans (GAGs) in the
development of bacterial keratitis, as in the case of Staphylococcus
aureus, responsible for 10–25% of cases and thus a leading cause
of this pathology (Hayashida et al., 2011; Park and Shukla, 2013).
GAGs are linear, anionic polysaccharides that appear as
part of a diverse group of glycoconjugates called proteoglycans
(PGs). They are expressed ubiquitously by all mammalian
cells, appearing inserted into the plasma membrane, or stored
in secretory granules, as well as being secreted into the
extracellular matrix (ECM). GAGs are composed of repeating
disaccharides including an amino sugar, N-acetylglucosamine
or N-acetylgalactosamine, and glucuronic acid or galactose.
Based on core disaccharide structures, GAGs are divided into
four groups: heparan sulfate (HS), chondroitin sulfate (CS),
keratan sulfate, and hyaluronic acid. Most GAGs display complex
heterogeneous structures resulting from the modification of the
molecule by a series of interdependent enzymatic reactions,
which can include N-deacetylation of N-acetylglucosamine,
usually followed by N-sulfation, epimerization of glucuronic acid
to iduronate, and diverse O-sulfations. The GAG chains are long,
ranging in molecular weight from 15 to over 100 kDa, meaning
the properties of GAGs tend to dominate the chemical properties
of PGs (Whitelock and Iozzo, 2005; Taylor and Gallo, 2006;
Schaefer and Schaefer, 2010; Iozzo and Schaefer, 2015).
A variety of normal and pathological functions have been
ascribed to GAGs, including cell adhesion and migration,
organization of the ECM, regulation of proliferation,
differentiation and morphogenesis, cytoskeleton organization,
tissue repair, inflamation, vascularization, and cancer metastasis
(Whitelock and Iozzo, 2005; Taylor and Gallo, 2006; Schaefer
and Schaefer, 2010; Iozzo and Schaefer, 2015). GAG functions
ultimately depend on the fine structure of the chains, composed
by specific sets of variably modified disaccharides, which defines
binding sites for a multitude of specific ligands, including
cytokines, chemokines, growth factors, enzymes and enzyme
inhibitors, and ECM proteins. Cell surface GAGs can also act
as coreceptors for various signaling receptors, or as endocytic
receptors for the clearance of bound ligands (Whitelock and
Iozzo, 2005; Taylor and Gallo, 2006; Schaefer and Schaefer, 2010;
Iozzo and Schaefer, 2015). These characteristics of GAGs and
PGs facilitate the specific interaction between host and pathogen
during infection. Many pathogens attack host cells by binding
to their GAGs, and interactions between GAGs and pathogen
proteins are often the decisive factor in the initial stages of
infection (Chen et al., 2008; Kamhi et al., 2013).
The purpose of this article is to analyze the role that GAGs
play in the adhesion of various pathogenic bacteria to corneal
epithelial cells. The study includes both Gram-positive and
-negative bacteria, and aims to identify whether GAGs are
involved in their binding to corneal cells, the role of each
molecular species, the PG molecules involved as well as their
main location (at the ECM or at the cell surface), and certain
molecular aspects of interaction, particularly the influence of
sulfations of the saccharide chains. Ultimately, understanding the
complexity of the adhesion process would allow for the possibility
of controlling bacterial infections via preventing the adhesion or
invasion stages of bacterial pathogenesis.
MATERIALS AND METHODS
Materials
The following materials were purchased from the manufacturers
indicated: HS, chondroitin sulfates A, B, and C (CS A,
CS B, and CS C), Heparinases I and III, chondroitinase
ABC, fluorescein isothiocyanate (FITC), and phospholipase
C phosphatidylinositol-specific (PI-PLC) from Bacillus
cereus, all from Sigma-Aldrich (St. Louis, MO, USA); 90%
DMEM/F-12 + GlutaMAXTM [Dulbecco’s Modified Eagle’s
medium F-12 Nutrient Mixture (Ham)], fetal bovine serum,
penicillin-streptomycin, insulin, EGF (epidermal growth factor
recombinant protein), and PBS (phosphate-buffered saline),
from Gibco-Thermo Fischer Scientific (Waltham, MA, USA);
HiTrap Desalting column and superose 12 from GE Healthcare
Life Sciences (Little Chalfont, UK); Brain-Heart Infusion
broth (BHI), from Pronadisa (Madrid, Spain); RNeasy Kit and
RNase-Free DNase, from Qiagen (Hilden, Germany); High-
Capacity cDNA Reverse Transcription Kit and PowerSYBR
Green PCR Master Mix, from Applied Biosystems (Foster City,
CA, USA); synthetic peptides were from Abyntek Biopharma
(Derio, Spain); mouse monoclonal anti-syndecan 1 (CD138),
from DakoCytomation (Carpinteria, CA, USA); and rabbit
anti-syndecan 2, goat anti-syndecan 3, and rabbit anti-syndecan
4 polyclonal antibodies, from Santa Cruz Biotechnology (Santa
Cruz, CA, USA).
Bacterial Strains and Cell Lines
The bacterial species used in this study were S. aureus (16491464),
Staphylococcus epidermidis (16546925), Streptococcus pyogenes
(16598698), Streptococcus pneumoniae (16171067), Escherichia
coli (16553780), Kebsiella pneumoniae (16589956), Serratia
marcescens (16583077), Neisseria gonorrhoeae (50264947),
Pseudomonas aeruginosa (16531445), and Haemophilus
influenzae (16091813), all of which were clinical isolates
obtained from the Hospital Universitario Central de Asturias.
All the bacteria were grown in Brain Heart Infusion (BHI
broth) at 37◦C in a shaking incubator, except S. pneumoniae, N.
Gonorrhoeae, and H. Influenzae, which were grown in a 5% (v/v)
CO2 atmosphere without shaking.
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HCE-2 [50.B1] ATCC CRL-11135 corneal cell line was
grown in Dulbecco’s Modified Eagle’s minimal essential medium
(DMEM). The culture broth was supplemented with 10% (w/v)
fetal bovine serum, 1.5 units/ml of insulin, 10 ng/ml of epidermal
growth factor (EGF), and with penicillin G/streptomycin (5000
IU/ml, 5000 µg/ml). Cultures were incubated at 37◦C in a 5%
(v/v) CO2 atmosphere.
Fluorescein Labeling
FITC labeling was performed on overnight cultures washed four
times with PBS and resuspended in a 0.1mg/ml FITC solution
to an A600 of 0.5; incubation in the dark at 37◦C under agitation
proceeded for 1 h and the bacterial suspensions were centrifuged,
once again washed four times with PBS to eliminate the FITC
excess, and resuspended in PBS to an A600 of 0.5.
Adherence Assays
Adhesion of the different pathogenic bacteria to HCE-2
monolayers was performed in 24-well plates to 70–90%
confluence. The media was aspirated, and the cells washed twice
with PBS and then blocked with 10% fetal bovine serum in
PBS for 2 h at 37◦C in a 5% CO2 atmosphere. After further
washing with PBS, 100 µl of FITC-labeled bacteria in 500 µl
of PBS buffer was added and the mixture incubated for 1 h at
37◦C and 5% CO2. Next, the wells were rinsed four times with
500 µl PBS to remove any unbound bacteria. At the end of the
experiment, HCE-2 cells were disaggregated with 1% SDS and the
fluorescence of the pathogens attached to them was quantified
in a Perkin Elmer LS55 fluorometer set at 488 nM (excitation)
and 560 nM (emission). Data for the different experiments were
normalized using the adhesion value without any additive or
treatment, which was given the arbitrary value of 1. Assays were
performed at least in triplicate and the data are expressed as the
mean± SD.
To analyze adhesion to the ECM, HCE-2 monolayers under
the same conditions as described above were lifted with 0.5mM
EDTA in PBS. The ECM (material remaining in the wells after
the cells had been lifted) was washed twice with PBS, and each
well was visually inspected to ensure that no cells remained.
The bacteria were then added and the assays were performed as
described above.
Inhibition of Glycosaminoglycan Synthesis
The cell cultures in 24-well plates at about 70% confluence were
incubated in medium containing rhodamine B 50 µg/ml or
genistein 30 µM (final concentration) overnight at 37◦C. The
cultures were washed twice with PBS, and submitted to adherence
assays, as described in the previous paragraph. Efficiency of
inhibition was tested by determining the concentration of GAGs
in the treated cells vs. the control cells as previously described
(Barbosa et al., 2003).
Enzymatic Digestion of Corneal
Cell-Surface GAGs
Hydrolysis of HS from cell cultures was achieved by incubation
at 37◦C for 3 h in a 5% CO2 atmosphere in DMEM minimal
medium with a mix of 500mU/ml (final concentration) of each
of heparinase I and III. Digestion of CS chains was carried
out by 3 h of incubation under the same conditions, but using
250mU/ml (final concentration) of chondroitinase ABC. The
hydrolysis of both GAGs was performed through simultaneous
incubation with heparinase I and III and chondroitinase ABC
under the same conditions. The reactions were stopped with
two washes in PBS buffer and the cell cultures were immediately
submerged in DMEM and adherence assays with pathogens
carried out as described above. The efficiency of digestions was
established by determining the concentration of GAGs in treated
cells vs. control cells as previously described (Barbosa et al.,
2003).
Adherence Inhibition Assays
The experiments examining the effect of GAGs on adherence
interference were performed through the addition of either
HS, CS A, CS B, and CS C, or a mixture of all four, at
concentrations ranging between 0.01 and 200 nM to the labeled
bacteria before their addition to the monolayers. However, the
assays comparing HS of high and low molecular weight (MW),
and those examining the differences between poorly and highly
sulfated HS domains used a concentration of 10 nM.
The effect of peptides which include consensus heparin
binding sequences on adherence interference experiments was
initially calibrated using the peptides QKKFKN and FKKKYGKS
at concentrations ranging between 1 and 500 nM, and measuring
the interference they produced on the binding of Pseudomonas
aeruginosa and Stapylococcus aureus. Based on these data, the
effect on all pathogens was analyzed at a concentration of 20 nM
of each peptide. The peptides were added to the monolayers
before the addition of the labeled bacteria.
Molecular Size Fractionation of HS
Molecular size fractionation of HS was carried out using
size-exclusion chromatography. One hundred microliters of a
1mg/ml HS solution including 10 nCi of [3H]HS were applied
to a superose 12 column connected to an FPLC system (GE),
and eluted with 50mM of pH 8.0 Tris-HCl buffer and 150mM
of NaCl at a flow rate of 1ml/min. One milliliter fractions were
collected, and HS eluting from the column was determined by
measuring radioactivity in aliquots of 200 µl of each fraction.
Fractions including molecules of either high or low MW were
pooled separately and then precipitated with 85% ethanol for 2 h
at−80◦C.
Obtaining of Highly and Poorly Sulfated
Domains from HS
Highly sulfated HS domains were obtained by digestion of HS
chains with heparinase III, and poorly sulfated HS domains were
obtained by digestion with heparinase I. In both cases 18 µg HS
were digested with 100 mU enzime in a 200 µl total volume of
sodium acetate buffer 100mM pH 6.8 including CaCl2 10mM.
RNA Isolation, cDNA Synthesis, and
qRT-PCR Reactions
RNA was isolated from corneal cells using the RNeasy
kit following the manufacturer’s specifications. Samples
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were subjected to treatment with RNase-free DNase
during the purification process itself. The concentration of
RNA obtained was determined spectrophotometrically by
measuring absorbance using a Picodrop Microliter UV/Vis
pectrophotometer (Picodrop Limited, UK).
cDNA synthesis was carried out using the High Capacity
cDNA Transcription Kit following the manufacturer’s
specifications. The reaction products were cleaned using
the PCR Clean-Up GenElute kit following the manufacturer’s
instructions.
qRT-PCR reactions were carried out as previously described
(Fernández-Vega et al., 2013), and actin was used as a control
gene to compare run variation and to normalize individual gene
expression. The expression values of the genes were calculated as
2−1Ct (relative to actin as the housekeeping gene).
Antibody Inhibition Assays
Antibody inhibition assays were carried out in 24-well plates and
grown to 80% confluence. The media was aspirated, and the cells
were washed twice with PBS and then blocked with 10% fetal
bovine serum in PBS for 2 h at 37◦C in a 5% CO2 atmosphere.
After further washing with PBS, anti syndecan-1, anti syndecan-
2, anti syndecan-3, or anti syndecan-4, or a mixture of all four,
in PBS were added and incubated for 1 h. All the antibodies were
diluted 1:100, except anti-SDC2, which was diluted 1:250. After
the treatments, adherence assays were performed as previously
indicated.
Enzymatic Removal of Glypicans Using
Phospholipase-C
PI-PLC was used to enzymatically remove glypicans from the cell
membrane. Cells were grown in 24-well plates to 80% confluence.
After washing with PBS, the cells were incubated in the absence
or presence of 80 mU/ml PI-PLC for 40 min at 37◦C in a 5%
CO2 atmosphere. After the treatment, adherence assays were
performed as detailed previously.
RNA Interference
Human lentiviral constructs for NDST1 (TRCN0000008648),
HS2OST1 (TRCN0000034936), and HS6ST1 (TRCN00000
34564) were purchased from Thermo Fischer Scientific.
Human lentiviral constructs for NDST1 and HS6ST1
were selected to include sequences shared by NDST2 and
HS6ST2 respectively. Lentiviral particles were produced by
cotransfection of 293T cells with the shRNA plasmid and
packaging vectors pMD2.G and psPAX2 (gifted by Didier
Trono; Addgene plasmids # 12259 and #12260, respectively)
according to the vendor’s instructions. Knockdown efficiency
was determined by qRT-PCR analysis as previously described
(Fernández-Vega et al., 2013).
Statistical Analysis
All analyses were performed using the Statistics for Windows
program (Statsoft Inc; Tulsa, OK). Mean values between two
samples were compared using the Mann-Whitney U-test, and
between multiple samples using the Kruskal-Wallis test. P< 0.05
was accepted as significant. All data are presented as means ±
standard error.
RESULTS
GAGs are Differentially Involved in the
Binding of Gram-Positive and
Gram-Negative Pathogens to Corneal
Epithelial Cells
To study whether GAGs mediate the binding of different
common corneal pathogens, including both Gram-positive
and Gram-negative bacteria, to corneal epithelial cells, their
biosynthesis was inhibited using either rhodamine B or genistein.
The results showed a decrease in the adherence of all the
bacteria investigated, suggesting that GAGs are involved in a
general way in the binding of pathogenic microorganisms to the
corneal epithelium (Figure 1A). However, the observed effect
was highly dependent on two factors: the inhibitor molecule used
and the Gram nature of the bacterium analyzed. Rhodamine B
diminished the binding of Gram-positive bacteria by 60% (±5.9),
while Gram-negative binding was decreased by only 23% (±8.9).
Moreover, GAG-devoid cells, obtained through treatment with
genistein, reduced Gram-positive and Gram-negative bacteria
binding by 44 (±3.7) and 60% (±14.8), respectively (Figure 1B);
However the peculiar behavior of P. aeruginosa, whose binding
decreased by only about 13%, demonstrates the high deviation
of the result obtained for the Gram-negatives, to the extent
that the exclusion of this microorganism results in a reduction
of 65% (±5). Statistical analysis showed significant values for
rhodamine B (p < 0.01) and a close to significant effect for
genistein (p = 0.08, p < 0.01 if Pseudomonas is excluded),
suggesting that inhibition by both molecules differentially affects
the binding of microorganisms depending on their Gram nature.
What is more, the two molecules produce opposite effects, such
that inhibition by rhodamine strongly affects binding of Gram-
positive bacteria, while genistein’s effect is more intense with
Gram-negatives (Figure 1B).
To investigate further the adherence of pathogens to the
GAGs, corneal cell surface GAGs were removed by digestion
with bacterial lyases, and the effect of this on the binding
of the different bacteria was determined. Treatment with
heparinase I and III or chondroitinase ABC reduced the
adherence of the pathogens in a similar manner, with no
statistically significant differences (Figure 1C). However, there
were differences when the effects on either Gram-positive or
Gram-negative pathogens were analyzed separately; treatment
with heparinases or chondroitinase reduced the adherence
of Gram-positive bacteria 35.5 (±7.05) and 40% (±5.2),
respectively, while the reduction for Gram-negatives were 22
(±2.6) and 22.5% (±4.9); the differences being statistically
significant for both treatments (p < 0.01; Figure 1D). In
the combined digestion employing both heparinases and
chondroitinase, adherence was significantly reduced compared to
in digestions using a single enzyme (p < 0.05 in all cases), and
statistically significant differences between Gram-positive and
Gram-negative were also detected (p< 0.01l Figure 1D).
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FIGURE 1 | Effect of decrease in cell GAGs on pathogen adhesion to
corneal epithelial cells. (A,B) Effect of inhibition of GAG biosynthesis.
(A) Inhibition of bacterial attachment to HCE-2 cells treated with rhodamine B
(gray bars) and genistein (black bars). (B) Differences in adherence to HCE-2
cells treated with rhodamine B or genistein between Gram-positive ( ) and
Gram-negative ( ) bacteria. Gram-negative data for binding to
genistein-treated cells are represented including or excluding ( )
Pseudomonas. (C,D) Effect of the pre-treatment of HCE-2 cell cultures with
GAG lyases. (C) Inhibition of bacterial attachment to HCE-2 cells treated with
heparinases I and III (gray bars), chondroitinase ABC (black bars) or
heparinases + chondroitinase (striped bars). (D) Adherence differences of
Gram-positive ( ) and Gram-negative ( ) bacteria to HCE-2 cells treated with
heparinases I and III, chondroitinase ABC or heparinases + chondroitinase.
Data were normalized using the adhesion values of bacteria to non-treated
cells, which was given the arbitrary value of 1. The spreads represent the
standard deviations. Statistically significant differences are denoted by **,
which indicates p < 0.01.
Distinct GAG Species Are Differentially
Involved in the Binding of Pathogens to
Corneal Epithelial Cells
To analyze the role that different species of GAGs play in the
adhesion of pathogens to corneal cells, adherence interference
experiments were performed using HS, CS A, CS B, CS C, and
a mixture of all four, as described in the Material and Methods
section. In all cases, the presence of GAG molecules decreased
the adherence of bacteria to corneal cells in a dose dependent
manner (Figure 2A). Furthermore, the effect was dependent on
the particular species of GAG used. In all cases, HS was the
most effective interfering molecule, followed by CS B, CS A and,
lastly, CS C, except in the case of the two species of Streptococcus
examined, where CS A showed a greater effect than CS B.
When a mixture of all GAGs was used, the effect was similar to
that obtained using HS alone, except in the cases of E. coli, S.
marcescens, P. aeruginosa, and H. influenzae, which the effect of
the combined treatment was greater (Figure 2A).
Taken together, the results evidence that both, HS and the
mixture of GAGs, have the highest inhibitory effect, although
the differences were not statistically significant (p = 0.1);
nevertheless, the two treatments did display differences when
compared to other species analyzed (p= 0.002, 0.04, and<0.001
for HS compared to CS A, CS B, and CS C, respectively;
Figure 2B). When the inhibitory effect of the different GAGs
was analyzed separately for Gram-positive and Gram-negative
bacteria, no significant differences was detected except in the case
of the mixture of all the species (p= 0.049; Figure 2C).
To analyze whether pathogens adhere primarily to corneal
epithelial cells or to the ECM, we prepared wells by detaching
the cells with EDTA, as described in Material and Methods. The
values of the adhesion of bacteria to the ECM were much lower
than those observed for cells (usually below 5%). Adherence
interference experiments carried out using the different GAG
species at 40 nM showed that the adherence of bacteria decreased
by around 10% with each of the CS types, by 21% for HS and
by 26% for the GAG mixture, all much lower than the values
obtained for the inhibition of adhesion to cells (Figure 2D).
HS Molecules Are Differentially Involved in
the Binding of Pathogens to Corneal
Epithelial Cells Depending on Their Size
and Sulfated Domains
Using size exclusion chromatography, HS was separated
into fractions of low (<10 kDa) and high (>10 kDa) MW
(Figure 3A). The effect of both fractions on the binding
of pathogens to corneal cells was analyzed by adherence
interference experiments. The results showed that high MW
HS decreased the adherence of bacteria around 20%, and this
value was independent of the Gram type of the microorganism
(Figures 3B,C). Interestingly though, low MW HS did display
different, and opposite, effects depending on whether bacteria
were Gram-negative or –positive: the former diminishing their
adhesion about 40%, and the latter around 20% relative to
controls (Figures 3B,C), and this difference was statistically
significant (p< 0.001).
HS chains are composed of highly sulfated NS-domains
interspaced with poorly sulfated NA-domains. These two domain
types were isolated by treatment with specific heparinases, and
then used to carry out adherence interference experiments
(Figure 3D). NS-domains in general were found to be twice as
effective in terms of inhibiting the binding of the bacteria (p <
0.01; Figure 3E); however, there were no significant differences
between the effect produced on Gram-positive or Gram-negative
bacteria by the two types of domain (Figure 3F).
Differential Interference of Peptides with
Heparin Binding Sequences in the Binding
of Gram-Positive and Gram-Negative
Pathogens to Corneal Epithelial Cells
Two peptides were designed which included consensus heparin
binding sequences of different lengths, the shorter being
QKKFKN, and the longer, FKKKYGKS. The effect of the
concentration of the two peptides on bacterial adherence to
HCE-2 cells was determined using the Gram-positive S. aureus
and the Gram-negative P. aeruginosa. In the case of S. aureus,
both peptides decreased adherence in a dose-dependent manner
up to concentrations of 10–20 nM, their effects diminishing at
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FIGURE 2 | Inhibition of pathogen attachment to corneal epithelial cells by the presence of different GAGs. (A) Adhesion of Staphyloccocus aureus (1),
Staphyloccocus epidermidis (2), Streptoccocus pyogenes (3), Streptococcus pneumoniae (4), Escherichia coli (5), Klebsiella pneumoniae (6), Serratia marcescens (7),
Neisseria gonorrhoeae (8), Pseudomonas aeruginosa (9), and Haemophilus influenzae (10) in the presence of different concentrations of HS ( ), CS A ( ), CS B ( ),
CS C ( ), and a mixture of all GAGs ( ). (B) Comparative effect of the different individual GAG species and the mixture of them all on bacterial adherence to corneal
cells. (C) Comparative effect of the different GAG species and the mixture on adherence of Gram-positive ( ) and Gram-negative ( ) bacteria. (D) Comparative effect
of the different individual GAG species and the mixture (40 nM) on bacterial adherence to ECM. The spreads represent the standard deviations. Statistically significant
differences are denoted by ***, **, and *, which indicate p < 0.001, p < 0.01, and p < 0.05, respectively and n.s. indicates that differences were not significant.
higher concentrations. In contrast, P. aeruginosa decreased its
adherence in the presence of the short peptide up to 20 nM,
while the longer peptide produced progressive interference, more
noticeable at higher concentrations (Figure 4A). On the basis
of these data, subsequent experiments were carried out at a
concentration of 20 nM for both peptides.
Results showed that the longer peptide decreased adherence
by about 20–30% for all the bacteria analyzed (Figure 4B).
However, the shorter peptide had a similar effect on Gram-
positive bacteria, but decreased the adherence of Gram-negative
bacteria about 50–60%, the difference between the two groups
being statistically significant (p< 0.001; Figure 4C).
Involvement of Cell-Surface HSPGs in the
Binding of Pathogens to Corneal Epithelial
Cells
To find out which species of HSPGs were present on the
membrane of the HCE-2 cells, the transcription levels of all the
isoforms of syndecans and glypicans were analyzed by qRT-PCR
reactions. The results showed the existence of transcripts for
each of the four syndecan isoforms, although their respective
levels varied in total by around three orders of magnitude, SDC4
and SDC1 being the most abundant, and SDC2 the most scarce
(Figure 5A). In contrast, transcripts were not detected for all
isoforms of glypicans and some appeared at only very low levels,
GPC1 being the most abundant species (Figure 5A).
To investigate the role of glypicans in the binding of
pathogens, they were removed from the cell surface using PI-
PLC, an enzyme that cleaves their glycosylphosphatidylinositol-
anchor. The results showed that this treatment only slightly
decreased bacterial adherence, and no differences between Gram-
positive and Gram- negative were detected (Figure 5B).
Since the four isoforms of syndecans were all transcribed
in HCE-2 cells, their individual involvement in adherence
was analyzed by blocking them using specific antibodies for
each species in separate experiments. The results obtained
were variable and, curiously, were not related to the apparent
levels of SDC isoforms derived from their transcription levels
(Figure 5B). Interestingly, when antibodies against the four
isoforms were used simultaneously in the experiment, adherence
decreased sharply, irrespective of the Gram nature of the
pathogen (Figure 5B).
Influence of Specific N- and O- Sulfations
on Pathogen Adherence to Corneal
Epithelial Cells
To further establish the influence of sulfation at specific positions
on the disaccharide unit of HS chains (Figure 6A), we used RNA
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FIGURE 3 | Effect of the HS chain size and sulfation of domains on pathogen attachment to corneal epithelial cells. (A–C) Effect of high and low MW HS
on pathogen attachment to corneal epithelial cells. (A) Size exclusion chromatography of HS; fractions collected, corresponding to areas of both high and low MW,
are shaded. (B) Effect on attachment of pathogens to HCE-2 cells: gray bars indicating high MW and black bars, low MW. (C) Adherence differences of Gram-positive
and Gram-negative bacteria in the presence of high and low MW HS. (D–F) Effect of highly and poorly sulfated HS domains on pathogen attachment to corneal
epithelial cells. (D) Effect on attachment of corneal pathogens: gray bars represent NA-domains and black bars, NS-domains. (E) Comparative effect of NA- and
NS-domains on bacterial adherence to corneal cells. (F) Adherence differences of Gram-positive ( ) and Gram-negative ( ) bacteria in the presence of HS NA- and
NS-domains. The spreads represent the standard deviations. Statistically significant differences are denoted by ***, and **, which indicate p < 0.001, and p < 0.01,
respectively. n.s. indicates that differences were not significant.
interference to silence the expression of the genes involved in
these reactions. Downregulation of N-sulfation of glucosamine
residues was carried out by silencing NDST1, which reduced
its expression with an efficiency of over 80%, and also reduced
the expression of NDST2 about 70%, without affecting C5-
glucuronate epimerization (GLCE), 2-O-sulfation (HS2ST1)
or 6-O-sulfation (HS6ST1 and HS6ST2). Downregulation of
2-O-sulfation of uronic acid residues was performed by
silencing HS2ST1, which reduced its expression with over 70%
efficiency without affecting N-sulfation or 6-O-sulfation. Finally,
downregulation of 6-O-sulfation of glucosamine residues was
carried out by silencing HS6ST1, reducing its expression with an
efficiency of over 80%, as well as the expression of HS6ST2 by
around 70%, without N-sulfation or 2-O-sulfation being affected
(Figure 6B).
Analysis of the adhesion of the pathogens to the knockout
clones showed that the decrease in sulfation reduced the binding
of all microorganisms tested. Interestingly, in all the cases, a
decrease in N- or 6-O-sulfation, both of which involve the
glucosamine residue, affected adherence to a greater extent
than a reduction in 2-O sulfation, which involves the uronic
acid residue (Figure 6C). When the effect on either Gram-
positive or -negative bacteria was analyzed separately, N- and
6-O-sulfation varied considerably depending on the bacterium
involved and differences between Gram type were not significant.
In contrast, 2-O sulfation presented more homogenous results
within each Gram type, with Gram-negative bacteria adherence
being reduced by around 40% on average and Gram-positive by
<30%, a difference that was statistically significant (p < 0.01;
Figure 6D).
DISCUSSION
The corneal epithelium is the eye’s interface with the environment
and, along with the other passive and active defense mechanisms,
it acts as a barrier against pathogens. The initial attachment
to host tissues is a critical event in pathogenesis, and a wide
spectrum of bacterial pathogens, including Helicobacter pylori,
Bordetella pertussis, Mycobacterium tuberculosis, and Chlamydia
trachomatis, bind to cell surface PGs, and the majority of them
have been shown to interact with their GAG moieties (Chen
et al., 2008). These considerations make it of interest to analyze
the involvement of corneal surface GAGs in adhesion and
colonization by different bacterial pathogens.
Levels of GAG chains in cultured corneal epithelial cells
were reduced either by enzymatic degradation with bacterial
lyases or by the use of specific inhibitors of their biosynthesis.
These treatments resulted in a significant decrease in bacterial
adherence in all cases, indicating that GAG chains are involved
in the attachment and colonization of bacteria. In addition,
treatment with heparinases and chondroitinase together had an
additive effect, suggesting the involvement of different species of
GAGs in bacterial adherence. Interestingly, the effects observed
in these experiments showed significant differences between
Gram-positive and -negative bacteria, suggesting a differential
use of GAGs as anchorage receptors for the two groups of
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FIGURE 4 | Effect of peptides with heparin binding sequences on
pathogen attachment to corneal epithelial cells. (A) Effect of peptide
QKKFKN on adherence of S. aureus ( ) and P. aeruginosa ( ), and effect of
peptide FKKKYGKS on adherence of S. aureus ( ) and P. aeruginosa ( ).
(B) Effect on pathogen attachment to corneal epithelial cells; gray bars:
QKKFKN 20nM; black bars: FKKKYGKS 20nM. (C) Adherence differences of
Gram-positive ( ) and Gram-negative ( ) bacteria in the presence of the short
or the long peptide. Statistically significant differences are denoted by ***,
which indicate p < 0.001. n.s., not significant.
FIGURE 5 | Involvement of cell surface HSPGs in the binding of
pathogens to corneal epithelial cells. (A) Differential transcription of cell
surface HSPGs in HCE-2 cells; values on the Y-axis are represented on a
logarithmic scale. (B) Relative adherence differences of Gram-positive ( ) and
Gram-negative ( ) bacteria after treatment with anti-SDC antibodies or with
PI-PLC. The spreads represent the standard deviations. Statistically significant
differences are denoted by ***, which indicates p < 0.001.
microorganisms. This differential use of GAGs as receptor could
be caused by the presence of different types of adhesins in the
two bacterial groups, including different types of pili and other
monomeric surface-bound adhesive proteins (Telford et al., 2006;
Virji, 2008; Kline et al., 2009). It is also interesting to note that the
inhibition of GAG synthesis resulted in significant and opposite
effects on the adherence of Gram-positive and -negative bacteria,
depending on the inhibitory molecule used: rhodamine strongly
affected the binding of Gram-positive bacteria, while genistein
produced a greater effect on Gram-negatives. Rhodamine B is
thought to inhibit chain elongation, acting as a non-specific
inhibitor that reduces GAG synthesis in a range of cells, and
produces decreased lysosomal GAG storage in some types of
mucopolysaccharidosis (Kaji et al., 1991; Roberts et al., 2006).
The isoflavone genistein inhibits the kinase activity of epidermal
growth factor receptors, which is required for full expression
of genes coding for enzymes involved in GAG production
(Piotrowska et al., 2006), although it has been described that
the effect of this molecule on GAG biosynthesis is strongly
dependent on their type and localization (Nikitovic et al., 2003).
Accordingly, all of these data indicate that the corneal pathogens
tested use GAGs, at least in part, as adhesion receptors, but they
display two clearly distinct patterns of in the way they use these
molecules, depending on their Gram nature.
The involvement of the predominant GAG species present
on the cell surface in the adhesion of pathogens was studied
by analyzing their ability to compete in adherence interference
experiments. HS showed the highest inhibitory ability, suggesting
that it constitutes the predominant cell surface receptor for all
the bacteria analyzed. With the exception of Streptococci, CS B
displayed the second highest inhibitory capacity, greater than
that obtained for CS A and -C. These data become of particular
relevance when considering that CS B is distinguished from
the other CS species by the presence, in variable proportions,
of iduronic acid, the C-5 epimer of glucuronic acid, which
generates a more flexible polysaccharide chain, allowing specific
interactions with several ligands, and that is also present in HS
chains (Thelin et al., 2013).
In Gram-positive microorganisms, the use of a mixture of
GAGs inhibited adhesion to the same extent as when using
only HS. However, in Gram-negative bacteria, the use of a
combination of GAGs increased inhibition by about 15% relative
to HS, and this value was statistically significant, suggesting that
in corneal epithelial cells HS is the main receptor for this group of
microorganisms, but that other GAG species are also involved in
a cooperative manner. The use of HS chains by different types
of epithelial cells as receptors has been described in different
pathogens, such as H. pylori (Ascencio et al., 1993), Neisseria
gonorrhoeae (Chen et al., 1995a), or S. aureus (Hayashida et al.,
2011), while others may use HS combined with other GAG
species, as in the case of Chlamydia trachomatis, which binds
to cervix-derived human epithelia through HS and CS B, but
not CS A or -C (Zaretzky et al., 1995), and S. pneumoniae,
which utilizes both HS and CS in the colonization of respiratory
epithelial cells (Tonnaer et al., 2006). Interestingly, in some
pathogens it has been described that different classes of GAGs
mediate attachment to different types of mammalian cells, such
as Borrelia burgdorferi, which uses HS to bind endothelial cells
and CS B and HS together to glial cells (Leong et al., 1998), and
Chlamydophila pneumoniae, which uses HS to bind epithelial
cells but not lymphoid Jurkat cells (Kobayashi et al., 2011).
In addition, in all the cases analyzed the bacteria bound more
efficiently to cells than to the ECM, a result analogous to those
described for the adherence of other pathogens to different cell
types, as in the case of L. interrogans (Breiner et al., 2009).
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FIGURE 6 | Influence of specific N- and O- sulfations on pathogen adherence to corneal epithelial cells. (A) Structure of an HS disaccharide unit showing
the genes involved in more common sulfations. Genes whose transcription can be detected in corneal epithelial cells are highlighted. (B) Differential transcription of
the genes encoding enzymes involved in HS sulfation in HCE-2 cells. The bars with increasingly darker colors indicate the control, and the clones in which N- sulfation,
2-O- sulfation and 6-O-sulfation were silenced, respectively. The arrows indicate downregulation of NDST (1), HS2ST1 (2), and HS6STs (3). NDST1 and -2:
N-deacetylase/N-sulfotransferase 1 and 2; GLCE: C5-glucuronate epimerase; HS2ST1: HS 2-O-sulfotransferase; HS6ST1 and -2: HS 6-O-sulfotransferase 1 and 2.
(C) Inhibition of bacterial attachment to HCE-2 cells with silencing of the genes involved in N-sulfation (black bars), 2-O- sulfation (gray bars), and 6-O-sulfation (striped
bars). (D) Relative adherence differences of Gram-positive ( ) and Gram-negative ( ) bacteria to clones in which N-sulfation, 2-O-sulfation and 6-O-sulfation were
silenced. The spreads represent the standard deviations. Statistically significant differences are denoted by **, which indicates p < 0.01. We used RNA interference to
silence the expression of the genes involved in these reactions.
Taken together, these data suggest that all the pathogens adhere
principally to the corneal cells and not to the ECM, and that they
predominantly use HS as receptor, although someGram-negative
bacteria seem to cooperatively use other GAGs.
HS is a complex linear biopolymer whose chains typically fall
within the range 14–45 kDa (Lindahl and Kjellén, 2013). The
length of the saccharide chain had a major effect on the binding;
as expected, the high molecular weight chains inhibited the
adherence of all pathogens similarly; however, the low molecular
weight chains enhanced the inhibitory effect on Gram-negative
microorganisms and, surprisingly, increased the adherence of
Gram-positives by around 20%. Although the addition of HS to
epithelial cells, which acts as a receptor, inhibits binding, there
are cases where the opposite effect occurs, such as the adhesion
of Neisseria gonorrhoeae to CHO cells, which is inhibited by high
concentrations of heparin, but increased at low concentrations
(Chen et al., 1995b). Furthermore, there are cases where the
size of a polymer has a determining influence on binding to
bacteria, such as with L. interrogans, which binds to high-
but not to low-molecular-weight dextran sulfate (Breiner et al.,
2009), and group B Streptococcus, in which GAG chain length
is important to bind the surface-anchored Alpha C protein
and promote bacterial entry into cervical epithelial cells in
vitro (Chang et al., 2011). Moreover, a possible mechanism
to explain the increase in adhesion of Gram-positive bacteria
caused by low molecular weight HS, could be the formation
of ternary complexes between bacterial adhesins, the HS and
protein receptors of the cell surface, as has been proposed in
the case of N. gonorrhoeae (van Putten and Paul, 1995) and
C. trachomatis (Kim et al., 2011). As regards the increased
inhibition observed in Gram-negative pathogens produced by
low molecular weight HS, some cases have been described in
which the size of the polymer greatly influences its inhibitory
effect; for instance, the effect of the GAG acharan sulfate on
the adhesion of Helicobacter pylori to Kato III cells (Sim et al.,
2011).
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Structurally, HS chains are composed of highly sulfated NS-
domains interspaced with poorly sulfated NA-domains. The
assay of both types of domains independently in adherence
interference experiments showed that those that were highly
sulfated had a greater inhibitory capacity than those poorly
sulfated, and this effect was general and not dependent on the
Gram nature of the pathogen. Although to our knowledge there
are no previous data referring to HS domains, some published
works have described that polymers that are more sulfated
display greater inhibitory potential, such as C. trachomatis, L.
interrogans, and group B Streptococcus (Zaretzky et al., 1995;
Breiner et al., 2009; Chang et al., 2011). Not surprisingly, the
interaction of HS with bacterial adhesins occurs to a greater
extent through the highly sulfated domains, since these sequences
are largely responsible for ligand binding, which depends to
some extent, but not uniquely, on interactions which are mainly
electrostatic in nature (Whitelock and Iozzo, 2005; Lindahl and
Kjellén, 2013).
Consistent with the concept that the positioning of sulfate
residues is critical for protein binding, most heparin binding
proteins have clusters of basic amino acid residues that have been
shown to be a requisite for heparin binding (Xu and Esko, 2014).
Although there are many cases in which a single linear sequence
does not define a HS-binding site, and two to three primary and
secondary elements usually make up the binding site, it has been
proposed that primary sequences composed of alternating basic
and hydropathic residues are candidates for defining HS-binding
motifs (Mulloy and Forster, 2000). We synthesized two peptides
which included putative heparin binding sequences, QKKFKN
and FKKKYGKS. Although both partially inhibited adhesion, the
effect was particularly interesting for the short sequence, whose
inhibition of Gram-negatives outweighed more than two-fold
the values for Gram-positive, a statistically significant difference.
These results suggest the involvement of proteins with different
heparin binding sequences in both groups of bacteria, which
could be related to the different nature of the adhesins described
in the twomicrobial groups (Telford et al., 2006; Virji, 2008; Kline
et al., 2009).
Generally, HS chains occur as glycoconjugates called
proteoglycans (HSPGs). Two gene families, syndecans, and
glypicans, account for most cell surface HSPGs, each of which
consists of four and six isoforms, respectively (SDC1-4 and
GPC1-6). Some previous studies have related specific species
of cell surface HSPGs with adhesion and colonization by
certain pathogens (van Putten and Paul, 1995; Chen et al., 2008;
Hayashida et al., 2011). Since HSPGs are expressed in differing
amounts depending on the tissue, we quantified their transcript
levels in HCE-2 cells. We found evidence for the existence of
transcripts of each of the four syndecan isoforms, but glypican
levels were extremely low or undetectable, with the exception
of GPC1. The experiments using enzymatic removal from the
cell surface or blocking using specific antibodies concluded
that syndecans are the main molecules involved in pathogen
adherence to corneal epithelial cells, and that all the isoforms
act in a cooperative way, independent of the Gram type of the
bacteria. Although as far as we are aware this is the first time
that a result of this type has been described, previous reports
have pointed to the cooperation of several species of syndecans
in pathogen binding, in particular links between SDC1 and
SDC4 for Listeria monocytogenes, Streptococcus pyogenes and
Staphylococcal sp., among others (Smith et al., 2006). Moreover,
regarding the low participation of glypicans in the binding
process, of particular interest is the case of Chlamydophila
pneumoniae, which uses GAGs for adherence to epithelial cells,
but whose adherence to lymphoid Jurkat cells, which only
express GPC1, is carried out by a mechanism independent of
GAGs (Kobayashi et al., 2011).
HS functions ultimately depend on the fine structure of
the chains. Specific sets of variably modified disaccharides,
usually within the sulfated domains, can define binding sites
for a multitude of specific ligands. To investigate the influence
sulfation at specific positions has on the disaccharide unit of
HS chains, we used RNA interference to silence the expression
of the genes involved in these reactions. The experiments have
an added complexity due to, on the one hand, the existence of
multiple isoforms responsible for some of these sulfations and,
on the other, by the possible existence of enzyme complexes
that are spatio-temporally regulated, both at the transcriptional
and translational level (Victor et al., 2009). To overcome the
problem of the isoforms, we selected lentiviral constructs which
included sequences shared by all the genes currently known
to be transcribed by HCE-2 cells. To verify that the specific
sulfation studied in each case was downregulated, and that
this fact did not affect the transcription of the epimerase and
the rest of sulfotransferases, the transcript levels of all the
genes involved were analyzed in each clone. Sulfation of the
amino group is catalyzed by four different isoforms of N-
deacetylase/N-sulfotransferases, NDST1-4; NDST3 and NDST4
are expressed primarily during embryonic development, but
NDST1 and NDST2 show broad overlapping tissue distribution
(Grobe et al., 2002), and the knockout of NDST1 effectively
reduced the expression of both genes. HS2ST1 is a unique
enzyme, but 6-O-sulfation is encoded by three genes, HS6ST1-3,
and only transcription for isoforms one and two can be detected
inHCE-2 cells, and our results showed that HS6ST1 silencing was
also able to reduce the expression of HS6ST2. In all the cases, the
knockout only affected the sulfation addressed.
Any reduction in sulfation affected the binding of pathogens,
which is consistent with the data described above suggesting
that these sulfated domains are largely responsible for bacterial
adhesion. However, inhibition of adhesion was strongly
influenced by the location of the sulfate group whose biosynthetic
genes had been silenced. Binding was very sensitive to sulfation
affecting the glucosamine residue, be it N- or 6-O-sulfation: In
contrast, 2-O sulfation of the uronic acid residue had a lesser
influence. Interestingly, the reduction in 2-O-sulfation was
the only situation whose effects showed significant differences
between Gram-positive and Gram-negative bacteria, resulting in
greater inhibition of adhesion in the latter, results that indicate
differences in interaction with the various adhesins from both
microbial groups.
In this study, we used corneal cell cultures to reveal the
involvement of GAGs in the adherence of pathogens to corneal
cells. Cell cultures have been widely used as models to investigate
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pathogenesis, and some of these works are referred to in this
article (Zaretzky et al., 1995; Chen et al., 1995b; van Putten
and Paul, 1995; Leong et al., 1998; Tonnaer et al., 2006; Breiner
et al., 2009; Chang et al., 2011; Kim et al., 2011; Kobayashi
et al., 2011; Sim et al., 2011). This approach has proved valid,
particularly for bacterial adherence, which constitutes the first
event in pathogenesis. However, it must be taken into account
that the situation in vivo displays many aspects which are not
present in homogeneous cultured cells (Cowell et al., 1999; Hume
et al., 2005). The complexities of the cornea, including variation
in shape, and function of epithelial cells, the presence of other cell
types, cell to cell communication or the immune system, points
to interesting possibilities for future analysis of the data using
animal models. Nevertheless, the molecular details described in
this paper could provide a springboard for the development of
new anti-infective strategies.
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